98%
921
2 minutes
20
Schistosomes are obligately sexual blood flukes that can be maintained in the laboratory using freshwater snails as intermediate and rodents as definitive hosts. The genetic composition of laboratory schistosome populations is poorly understood: whether genetic variation has been purged due to serial inbreeding or retained is unclear. We sequenced 19 - 24 parasites from each of five laboratory Schistosoma mansoni populations and compared their genomes with published exome data from four S. mansoni field populations. We found abundant genomic variation (0.897 - 1.22 million variants) within laboratory populations: these carried on average 62% (π = 1.52e-04 - 7.15e-04) less nucleotide diversity than the four field parasite populations (π = 9.06e-03 - 2.24e-03). However, the pattern of variation was very different in laboratory and field populations. Tajima's D was positive in all laboratory populations (except SmBRE), indicative of recent population bottlenecks, but negative in all field populations. Current effective population size estimates of laboratory populations were lower (2 - 258) compared to field populations (3,174 - infinity). The distance between markers at which linkage disequilibrium (LD) decayed to 0.5 was longer in laboratory populations (59 bp - 271 kb) compared to field populations (9 bp - 17.1 kb). SmBRE was the least variable laboratory population; this parasite also shows low fitness across the lifecycle, consistent with inbreeding depression. The abundant genetic variation present in most laboratory schistosome populations has several important implications: (i) measurement of parasite phenotypes, such as drug resistance, using laboratory parasite populations will determine average values and underestimate trait variation; (ii) genome-wide association studies (GWAS) can be conducted in laboratory schistosome populations by measuring phenotypes and genotypes of individual worms; (iii) genetic drift may lead to divergence in schistosome populations maintained in different laboratories. We conclude that the abundant genetic variation retained within many laboratory schistosome populations can provide valuable, untapped opportunities for schistosome research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377630 | PMC |
http://dx.doi.org/10.1371/journal.ppat.1013439 | DOI Listing |
The anthelmintic praziquantel (PZQ) has been used for decades as the clinical therapy for schistosomiasis, and remains the only available drug. As a cheap and effective drug therapy for all human disease-causing species, usage of PZQ underpins mass drug administration strategies aimed at eliminating schistosomiasis as a public health problem by 2030. Concern over the potential emergence of resistance to PZQ is therefore warranted, as it would constitute a major threat to this approach.
View Article and Find Full Text PDFFront Cell Infect Microbiol
September 2025
Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
The escalating cancer burden in Sub-Saharan Africa (SSA), with projected doubling of incidence and mortality by 2040, necessitates innovative, cost-effective strategies for prevention, diagnosis, and treatment. While known infectious triggers like HPV, hepatitis viruses, and account for an estimated 28.7% of cancers in SSA, the full scope of microbially-mediated oncogenesis remains underexplored.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
Pelagic Ecology Research Group, School of Biology, Gatty Marine Laboratory, Scottish Oceans Institute, University of St Andrews, St Andrews, Fife, United Kingdom.
In areas of high infection prevalence, effective control of schistosomiasis - one of the most important Neglected Tropical Diseases - requires supplementing medical treatment with interventions targeted at the environmental reservoir of disease. In addition to provision of clean water, reliable sanitation, and molluscicide use to control the obligate intermediate host snail, top-down biological control of parasite-competent snails has recently gained increasing interest in the scientific community. However, evidence that natural predators can effectively reduce snail abundance and, ultimately, transmission risk to vulnerable human populations remains limited.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom.
Direct morbidity assessments are rarely included in monitoring and evaluation of Schistosoma mansoni mass drug administration programmes. This is despite morbidity reduction being the leading objective of control and elimination as a public health problem in the World Health Organization (WHO) targets. Instead, the number of eggs-per-gram (EPG) of faeces are used as a morbidity proxy.
View Article and Find Full Text PDFBMC Immunol
September 2025
Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, USA.
Background: Urogenital schistosomiasis caused by affects over 100 million people globally, with potential long-term genetic and immunological consequences poorly understood in endemic populations. This study investigates genetic damage and immune dysregulation in infected individuals from a hyperendemic region in Nigeria.
Objective: To quantify genetic damage markers and characterize immune system alterations in individuals with confirmed infection compared to uninfected controls from Atisbo Local Government Area, Oyo State, Nigeria.